Literature DB >> 19783316

Improvements in life expectancy in type 1 diabetes patients in the last six decades.

Sorin Ioacara1, Radu Lichiardopol, Constantin Ionescu-Tirgoviste, Dan Cheta, Sorin Sabau, Cristian Guja, Eugenia Farcasiu, Cristina Tiu.   

Abstract

AIMS: To investigate the survival with diabetes in patients treated with insulin from diagnosis. SUBJECTS AND METHODS: We analyzed 845 subjects, 55.9% males, registered at "I. Pavel" Bucharest Diabetes Centre, insulin-treated from diagnosis, aged <40 years and deceased between 1946 and 2005. We divided the subjects in two groups by age at diagnosis: group A <18 years and group B 18-39.99 years. We used 20 years time periods for year of death: 1946-1965, 1966-1985 and 1986-2005.
RESULTS: The mean age at diabetes onset was 30.36+/-8.04 years, disease duration at death 20.98+/-11.62 years and age at death 51.34+/-14.37 years. The mean increase in survival with diabetes was 19.3 years for group A and 15.9 years for group B. There was a significant decrease in infections in both groups. The increase in coronary heart diseases and stroke is evident only in group B.
CONCLUSIONS: We found no changes in age at onset, which combined with an increase in survival with diabetes lead to a significant increase in age at death over the six decades analyzed.

Entities:  

Mesh:

Year:  2009        PMID: 19783316     DOI: 10.1016/j.diabres.2009.08.012

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  10 in total

1.  Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia-mediated ERK1/2-NF-κB signaling pathway.

Authors:  Tianyu Zhang; Hao Ouyang; Xiyu Mei; Bin Lu; Zengyang Yu; Kaixian Chen; Zhengtao Wang; Lili Ji
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  Epidemiology of diabetes and diabetes complications in the elderly: an emerging public health burden.

Authors:  Mark Corriere; Nira Rooparinesingh; Rita Rastogi Kalyani
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

3.  Use of a Smartphone Application to Reduce Hypoglycemia in Type 1 Diabetes: A Pilot Study.

Authors:  Carly Feuerstein-Simon; Suzan Bzdick; Amitha Padmanabhuni; Puneetpal Bains; Cheryl Roe; Ruth S Weinstock
Journal:  J Diabetes Sci Technol       Date:  2018-01-01

Review 4.  Effect of systemic medications on onset and progression of diabetic retinopathy.

Authors:  Paolo S Silva; Jerry D Cavallerano; Jennifer K Sun; Lloyd M Aiello; Lloyd Paul Aiello
Journal:  Nat Rev Endocrinol       Date:  2010-07-27       Impact factor: 43.330

5.  Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults' Glycemia in T1DM subanalysis.

Authors:  Norio Abiru; Akira Shimada; Rimei Nishimura; Munehide Matsuhisa; Asuka Ozaki; Hiroshi Ikegami
Journal:  Diabetol Int       Date:  2021-04-25

6.  Life expectancy of type 1 diabetic patients during 1997-2010: a national Australian registry-based cohort study.

Authors:  Lili Huo; Jessica L Harding; Anna Peeters; Jonathan E Shaw; Dianna J Magliano
Journal:  Diabetologia       Date:  2016-01-21       Impact factor: 10.122

7.  DNA-PK phosphorylation of IGFBP-3 is required to prevent apoptosis in retinal endothelial cells cultured in high glucose.

Authors:  Qiuhua Zhang; Jena J Steinle
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-30       Impact factor: 4.799

Review 8.  A meta-analysis of the relative risk of mortality for type 1 diabetes patients compared to the general population: exploring temporal changes in relative mortality.

Authors:  Tom W C Lung; Alison J Hayes; William H Herman; Lei Si; Andrew J Palmer; Philip M Clarke
Journal:  PLoS One       Date:  2014-11-26       Impact factor: 3.240

9.  Cognition in Adults and Older Adults With Type 1 Diabetes: Chicken or Egg?

Authors:  Naomi S Chaytor
Journal:  Diabetes Spectr       Date:  2016-11

10.  Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.

Authors:  Rachel G Miller; Aaron M Secrest; Ravi K Sharma; Thomas J Songer; Trevor J Orchard
Journal:  Diabetes       Date:  2012-07-30       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.